Control of plasma aldosterone in diabetic patients with hyporeninemic hypoaldosteronism
- PMID: 204828
- DOI: 10.1007/BF01477829
Control of plasma aldosterone in diabetic patients with hyporeninemic hypoaldosteronism
Abstract
In three patients with diabetes and hyporeninemic hypoaldosteronism changes in renin activity, plasma aldosterone and cortisol were examined under various conditions: orthostasis and intravenous furosemide, infusion of synthetic beta1-24 ACTH on two consecutive days and diurnal variations in basal hormone fluctuations. Each patient showed unmeasurably low renin activity unresponsive to orthostasis and intravenous furosemide while plasma aldosterone was below normal range. Under ACTH-infusion only marked increases in aldosterone were observed in one patient whereas cortisol responded normally in all diabetics tested. Analysis of diurnal night day fluctuations (20.00-8.00) in plasma aldosterone and cortisol revealed a close and statistically significant relationship between both hormones in each of the three patients (p less then 0.05-less than 0.001). Variations in plasma aldosterone thus were mediated through changes in endogenous pituitary ACTH. Compared with normal controls however, diurnal aldosterone curves were set at a lower level. Our results demonstrate that a reduced sensitivity of the adrenal gland to ACTH is not responsible for the observed subnormal plasma aldosterone levels in these patients. Therefore, the lack of circulating angiotensin II seems to be the causative reason of hypoaldosteronism. The exact mechanism of undetectable renin activity in these patients remains unknown.
Similar articles
-
Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism.Acta Endocrinol (Copenh). 1989 Jul;121(1):83-9. doi: 10.1530/acta.0.1210083. Acta Endocrinol (Copenh). 1989. PMID: 2545066
-
Reversible hyporeninemic hypoaldosteronism in a patient with tetraplegia.Endocrinol Jpn. 1989 Feb;36(1):1-7. doi: 10.1507/endocrj1954.36.1. Endocrinol Jpn. 1989. PMID: 2543544
-
Studies of the renal vasoactive systems in hyporeninemic hypoaldosteronism.Prostaglandins Med. 1981 Jun;6(6):549-56. doi: 10.1016/0161-4630(81)90116-6. Prostaglandins Med. 1981. PMID: 6267637
-
Unresponsiveness of plasma mineralocorticoids to angiotensin II in diabetic patients with asymptomatic normoreninemic hypoaldosteronism.J Lab Clin Med. 1985 Feb;105(2):195-200. J Lab Clin Med. 1985. PMID: 2982980
-
Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management.World J Diabetes. 2016 Mar 10;7(5):101-11. doi: 10.4239/wjd.v7.i5.101. World J Diabetes. 2016. PMID: 26981183 Free PMC article. Review.
Cited by
-
Therapeutic Renin Inhibition in Diabetic Nephropathy-A Review of the Physiological Evidence.Front Physiol. 2020 Mar 12;11:190. doi: 10.3389/fphys.2020.00190. eCollection 2020. Front Physiol. 2020. PMID: 32231590 Free PMC article. Review.